Evidence map›Paper›PMID 38293396›Full record

ArticleHeliyon2024

Adjuvant activity of cordycepin, a natural derivative of adenosine from

Xin Chen, Boyu Liao, Tianci Ren, Zhipeng Liao, Zijie Huang, Yujuan Lin, Shouhao Zhong, Jiaying Li, Shun Wen, Yingyan Li and 8 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Heliyon, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.9field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 3 institutions in 1 country.

Xin ChenCollege of Pharmacy, Shenzhen Technology University, Shenzhen, 518118, China.
Boyu LiaoCollege of Pharmacy, Shenzhen Technology University, Shenzhen, 518118, China.
Tianci RenCollege of Pharmacy, Shenzhen Technology University, Shenzhen, 518118, China.
Zhipeng LiaoCollege of Pharmacy, Shenzhen Technology University, Shenzhen, 518118, China.
Zijie HuangCollege of Pharmacy, Shenzhen Technology University, Shenzhen, 518118, China.
Yujuan LinCollege of Pharmacy, Shenzhen Technology University, Shenzhen, 518118, China.
Shouhao ZhongCollege of Pharmacy, Shenzhen Technology University, Shenzhen, 518118, China.
Jiaying LiCollege of Pharmacy, Shenzhen Technology University, Shenzhen, 518118, China.
Shun WenCollege of Pharmacy, Shenzhen Technology University, Shenzhen, 518118, China.
Yingyan LiCollege of Pharmacy, Shenzhen Technology University, Shenzhen, 518118, China.
Xiaohan LinCollege of Pharmacy, Shenzhen Technology University, Shenzhen, 518118, China.
Xingchen DuCollege of Pharmacy, Shenzhen Technology University, Shenzhen, 518118, China.
Yuhui YangCollege of Pharmacy, Shenzhen Technology University, Shenzhen, 518118, China.
Jiubiao GuoCollege of Pharmacy, Shenzhen Technology University, Shenzhen, 518118, China.
Xiaohui ZhuCollege of Pharmacy, Shenzhen Technology University, Shenzhen, 518118, China.
Haishu LinCollege of Pharmacy, Shenzhen Technology University, Shenzhen, 518118, China.
Rui LiuLaboratory of Molecular Immunology, State Key Laboratory of Genetic Engineering, School of Life Sciences, Fudan University, Shanghai, 200438, China.
Jingbo WangCollege of Pharmacy, Shenzhen Technology University, Shenzhen, 518118, China.
Shenzhen Technology University · CNShenzhen University Health Science Center · CNFudan University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Vaccination is the most feasible way of preventing rabies, an ancient zoonosis that remains a major public health concern globally. However, administration of inactivated rabies vaccination without adjuvants is always inefficient and necessitates four to five injections. In the current study, we explored the adjuvant characteristics of cordycepin, a major bioactive component of

Indexed as

AdjuvantCordycepinRabies vaccine

Identifiers

PMID38293396
PMCPMC10826310
OpenAlexW4390815925

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.